Canadian consensus on osteoporosis. Preventing osteoporosis among postmenopausal women.
D000368:Aged; D019386:Alendronate / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002170:Canada; D015914:Estrogen Replacement Therapy; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000517:prevention & control*; D011322:Primary Prevention / Q000379:methods*; D000068296:Risedronic Acid; D018570:Risk Assessment
D002121:Calcium Channel Blockers; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate